Xeris Pharmaceuticals
- Biotech or pharma, therapeutic R&D
Xeris Biopharma (NASDAQ: XERS) is a commercial stage biopharmaceutical company, commercializing therapeutics in Endocrinology, Neurology and rare diseases, and leveraging proprietary non-aqueous formulation platforms to develop novel ultra highly concentrated (>450mg/mL), ready-to-use, subcutaneously injectable biologics and small molecule drugs
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}